Skip to main content

Data and analytics trends and insights

Discover how complete and accurate data can identify trends and uncover new ways to improve operations, market research and health outcomes. 

Latest featured insights

Article

4 ways small biopharma can harness RWD

Small and emerging biopharma companies are already having an impact on the industry. Learn how RWD can enhance the ability to innovate.

Article

Reassessing the Inflation Reduction Act with real-world evidence

Cut through the noise of the Inflation Reduction Act of 2022 with key points aimed to help life sciences leaders leverage impactful data.

Article

Catalyze the use of RWE in life sciences

Discover how using real-world evidence (RWE) in the life sciences industry can help catapult learning and drive impact for your company.

Article

Unlock clinical insights with NLP technology

Learn about natural language processing (NLP) challenges and opportunities in the real-world data (RWD) space from Optum® NLP experts.

 

 

Latest articles

Article

4 ways small biopharma can harness RWD

Small and emerging biopharma companies are already having an impact on the industry. Learn how RWD can enhance the ability to innovate.

Article

Reassessing the Inflation Reduction Act with real-world evidence

Cut through the noise of the Inflation Reduction Act of 2022 with key points aimed to help life sciences leaders leverage impactful data.

 

 

Latest case studies and testimonials

Case study

Generating new data voice to claim research

Using our Voice-to-Claim® methodology to better understand the attitudes and behaviors of patients and physicians and their effects on cost and utilization.

Case study

Using data to monitor behavioral health services

See how Optum helped one state visualize utilization and demographic data around ‌behavioral health programs.

Case study

Improved Arkansas Medicaid Outcomes

Optum has completed more than 200K+ assessments in Arkansas, helping coordinate care for people with chronic, high-cost and long-term care needs.

 

 

Latest e-books

E-book

The 6 trends shaping pharma strategies in 2024

Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.

E-book

Assess drug performance with integrated data

Explore real-world use cases to see how integrated data empowers research and commercial teams to compete in today’s crowded market.

 

 

Latest guides

Guide

Real-world data centralized teams

Expanding the use of RWD requires expertise and leadership. Learn how to maximize the success of a centralized RWD team.

Guide

Informing FDA best initiative

As a key FDA collaborator, Optum Epidemiology generates reproducible results that inform regulatory decisions for COVID-19 vaccines.

 

 

Latest on-demand webinars

On-demand webinar

How to maximize ROI real world data

Optum experts give a snapshot of commonly encountered pitfalls when using RWD and recommendations to help avoid them in this PMSA webinar.

On-demand webinar

Increasing potential of genomic data

Hear from experts in this Endpoints News webinar on the increasing importance of clinicogenomic data, including diverse phenotypic and genotypic profiles.

 

 

Latest white papers

Guide

Real-world data centralized teams

Expanding the use of RWD requires expertise and leadership. Learn how to maximize the success of a centralized RWD team.

White paper

Using clinicogenomics to advance research

Rich, longitudinal clinicogenomics data can fuel all stages of drug development.

White paper

NLP methods for RWD insights

Natural language processing (NLP) systems allow us to draw insights from billions of unstructured medical notes. Learn more about our methodology.

 

 

Latest videos

Video

How states can serve members more holistically

Lori Halpern and Dennis Vaughan discuss interoperability, helping communities address the growing mental health crisis and new ways of delivering care.

Video

Maximize Your Real-World Data Strategy

Optum Life Sciences leaders break down common missteps when using RWD and how to create practical strategies to overcome them. Watch the video from STAT Summit.

  

 All data and analytics insights

Increasing potential of genomic data

Hear from experts in this Endpoints News webinar on the increasing importance of clinicogenomic data, including diverse phenotypic and genotypic profiles.

Maximize Your Real-World Data Strategy

Optum Life Sciences leaders break down common missteps when using RWD and how to create practical strategies to overcome them. Watch the video from STAT Summit.

What if providers’ clinical data were research-ready?

Providers collect data about patients every day. But what should they be considering — and doing — to put their clinical data to good use?

Utilize technology to harness disparate data

Invest in long-term fraud prevention.

Partnering to reduce fraud, waste and abuse

We partner with federal agencies to address challenges and support their unique needs through technologies, solutions and best practices.

States achieve health equity with actionable analytics

By applying analytics solutions, states can create a comprehensive roadmap to better health equity.

Lowering cardiovascular disease risk

An innovative program involving patient awareness and provider outreach improves patient use of lipid-lowering therapies.

Identifying patients' bone fracture risk

Optum Life Sciences experts used real-world data to assist in the testing of an algorithm designed to assess for osteoporosis risk.

Expanding health equity in clinical trials

Jamie Freedman, MD, PhD, and Shalini Mohan, MD, discuss challenging assumptions about expanding diversity and representation in clinical trials.

Break down silos in clinical trial design

Clinical trial protocol design and feasibility often occur in silos. Learn how to make the overall trial design process more effective with RWD and other tools.

Using the right tools to approach RWD

RWD pitfalls part 1: When working with real-world data, learn from the lessons of others to help maximize your own business return.

Deliver program integrity efficiencies

We help federal agencies with an effective data strategy and analytic roadmap to predict and prevent fraud, waste and abuse.

Real-world data centralized teams

Expanding the use of RWD requires expertise and leadership. Learn how to maximize the success of a centralized RWD team.

NLP methods for RWD insights

Natural language processing (NLP) systems allow us to draw insights from billions of unstructured medical notes. Learn more about our methodology.

4 ways small biopharma can harness RWD

Small and emerging biopharma companies are already having an impact on the industry. Learn how RWD can enhance the ability to innovate.

Integrated RWD: The key to accelerating innovation

To maximize the value of clinical innovations, you need dimensional, robust data. Learn about leveraging integrated cost and clinical data.

Solve contract challenges for gene therapies

Gene therapies have the potential to be transformative, but there are hurdles to overcome for value-based contracts to become widespread.

Applying robotic process automation compliance

See how robotic process automation (RPA) helped saved 9,465 hours and $950,000 over five years in our client use case example.

Real-world data fills rare disease data gaps

Read how you can fill the data divide to develop effective treatment options.

Assess drug performance with integrated data

Explore real-world use cases to see how integrated data empowers research and commercial teams to compete in today’s crowded market.

Race ethnicity data bridge gap in health equity

The life sciences industry needs robust real-world data. For that data to reflect real-world populations, you need race and ethnicity data.

Solving clinical trial recruitment challenges

Watch clinical trial leaders from Optum and Biogen discuss how to address trial recruitment struggles by unlocking real-world data (RWD).

Is your real world data research ready

Real-world data can help evaluate the effectiveness of medications and therapies, which is why evaluation should be part of the investment.

Improved Arkansas Medicaid Outcomes

Optum has completed more than 200K+ assessments in Arkansas, helping coordinate care for people with chronic, high-cost and long-term care needs.

Using epidemiological data build public confidence

See how the FDA and Optum use real-world evidence to monitor the safety and effectiveness of COVID-19 vaccines in our youngest populations.

Toward outcomes-based payments

Learn from industry leaders about the push to generate evidence and demonstrate healthcare provider value.

Latest takes in-life sciences industry

Discover what’s on the minds of innovative life science leaders with thought -provoking insights and discussions.

Patient access to gene therapies for rare disorders

Optum Life Sciences experts discuss value-based contracts at the 5th Annual Gene Therapy for Rare Disorders Conference.

Improving SGLT2i therapy guideline adherence

A manufacturer worked with Optum Life Sciences to help increase guideline adherence for patients with diabetes and cardiovascular disease.

Take action maximize impact real world data

We design programs between life sciences companies, payers, providers and patients to improve care and patient and provider satisfaction.

Tips for selecting a fit for purpose data set

Using real-world data (RWD) that are not fit for purpose can waste time and money. Review 6 simple steps to guide your research towards the right data.

Informing FDA best initiative

As a key FDA collaborator, Optum Epidemiology generates reproducible results that inform regulatory decisions for COVID-19 vaccines.

How to maximize ROI real world data

Optum experts give a snapshot of commonly encountered pitfalls when using RWD and recommendations to help avoid them in this PMSA webinar.

Using data to monitor behavioral health services

See how Optum helped one state visualize utilization and demographic data around ‌behavioral health programs.

Analytics in payer-oncologist partnerships

See 4 ways that payers can help healthcare providers unlock the power of real-world data to drive quality and innovation in cancer care.

The 6 trends shaping pharma strategies in 2024

Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.

Catalyze the use of RWE in life sciences

Discover how using real-world evidence (RWE) in the life sciences industry can help catapult learning and drive impact for your company.

Automate fraud waste abuse improve program integrity

Learn how artificial intelligence (AI) and natural language processing (NLP) can help federal agencies improve program integrity, cut costs and deter fraud.

Robotic process automation (RPA)

We utilize RPA to advance federal government programs.

Visualizing fraud, waste and abuse

Graph analytics and machine learning drive the future of program integrity.

Redefining the prior authorization process

Learn how we are revamping the prescribing process.

Collaborating to advance maternal health

Learn how leaders, communities and institutions can work with Optum to promote safe pregnancies and childbirth.

Targeted care, lower costs

One state achieved both aims in delivering home health services.

Generating new data voice to claim research

Using our Voice-to-Claim® methodology to better understand the attitudes and behaviors of patients and physicians and their effects on cost and utilization.

How VBC can work for manufacturers

Value-based contracts can present challenges that must be overcome to bring gene therapies to market.

Determining treatment safety for pregnancy and infants

Studying the impact of treatments on pregnancy and infants can help patients, providers and pharmaceutical companies make key decisions.

New dimensions in life sciences research

Proving the impact on clinical outcomes as well as costs.

Optum Serve: Protecting taxpayer dollars

Eliminate fraud, waste and abuse in healthcare spending.

Insomnia treatment research study

Optum combined real-world data and primary research to create better understanding of insomnia and help create new treatments.

Monitoring COVID-19 vaccine safety

Discover insights from Dr. John Seeger’s recent participation at the Duke-Margolis Thirteenth Annual Sentinel Initiative Public Workshop.

The unifying power of integrated data

Read how the integration of EHR and claims data can change what we can collectively learn about outcomes.

Optum, FDA collaborate on vaccine and biologic research

FDA reaches agreement with life sciences segment of Optum to provide data and expertise to evaluate and research biologics and vaccines.

Top stakeholder questions to consider

Ask your life sciences stakeholders what they need early on. Consider these top questions that patients, providers, payers and regulators are looking to answer.

Stay current on core claims systems releases

Stay current on core claims systems releases See how upgrade as a service from Optum helps health plans stay up-to-date on admin and core claims platform releases.

Address the complexity of the claims process

Read the interview for insights into how state leaders can reduce administrative cost and support collaboration with providers.

Strategies for incremental modernization

States can build on a step-by-step approach to modernization, incrementally transforming the user experience without disruption.

The fight for techquity

Get ideas for how to fundamentally change your approach to building technology and incorporate techquity into your organization.

Strategies to reduce administrative costs

Strategies to fix payer-provider collaboration, streamline patient financial experience and apply AI technologies for better cost savings.

Value assessment frameworks

This interview with Jason Spangler, MD, MPH, FACPM, is part of the "Let's Talk" conversation series.

Symmetry EBM Connect

Increasing compliance with evidence-based standards to enhance care.

Precision medicine trends: A conversation with Chris Boone, PhD

AbbVie Vice President Chris Boone discusses what the life sciences industry can do to realize precision medicine’s full potential.

Symmetry Oncology Analytics

Learn about powerful tools to measure the cost and quality of cancer care.

Arkansas' new approach to Medicaid management

See how data and analytics help Arkansas manage one of the state's most vital and widely used government programs.

Using clinicogenomics to advance research

Rich, longitudinal clinicogenomics data can fuel all stages of drug development.

New mandatory CMS reporting rules will impact states

To meet the requirements, states should consider focusing on five key areas.

9 ways to modernize the Medicaid experience

Read our 9 key takeaways for states to modernize the provider management experience.

Modernizing the Medicaid experience

How can states and providers use modularity to modernize? Dustin Haisler at GovTech.com interviews Optum product leaders for insights.

How states can serve members more holistically

Lori Halpern and Dennis Vaughan discuss interoperability, helping communities address the growing mental health crisis and new ways of delivering care.

Healthier outcomes for moms and babies

By using enterprise data to reach out to women earlier in pregnancy, one state is supporting moms and babies and creating healthier outcomes for both with help from Optum.

Supporting care for at-risk minors

Learn about a lightweight, scalable foster-family placement system developed for one Northeastern state.

What if pragmatic clinical trials were more practical

Pragmatic trials look increasingly attractive to researchers, but they’re tough to execute. Learn how to simplify the process.

Reducing avoidable Medicaid claims denials

In this GovTech.com interview with John Campbell of Optum State Government Solutions, see how the right technology can modernize the claims process.

Partnering to close gaps in maternal health

Learn how we can collaborate with your state to use analytics and consulting to address your most important maternal health challenges.

Evidence in Action newsletter

Our quarterly e-newsletter helps you stay up to date with current issues facing life sciences leaders and the role of real-world evidence.

Design an exceptional physician review strategy

Optimize your physician review process to help save time, reduce costs and improve care quality.

The value of clinical notes

What more is there to the patient story? Get deeper data insight into patient-clinician interactions with de-identified clinical notes.

Reassessing the Inflation Reduction Act with real-world evidence

Cut through the noise of the Inflation Reduction Act of 2022 with key points aimed to help life sciences leaders leverage impactful data.

CMS quality measure rules 2024

Upcoming changes in federal quality measures for Medicaid and CHIP will impact state governments.

Unlock clinical insights with NLP technology

Learn about natural language processing (NLP) challenges and opportunities in the real-world data (RWD) space from Optum® NLP experts.

DC maternal health homelessness

Learn about our collaborative approach to promoting maternal health in Washington, D.C., with a focus on homelessness and perinatal care.

Which growth strategy path is right for you?

Discover which growth strategy path is right for your health system.

Reexamine the effect of the Inflation Reduction Act

Learn how real-world data and evidence can help prepare you for healthcare-related Inflation Reduction Act policies.

Social determinants of health in urban America

Learn more about addressing social determinants of health in Brooklyn, NY.

How real-world evidence can inform pharma strategies in 2025

Health economics and outcomes research (HEOR) can play a key role in helping the life sciences industry improve patient outcomes.

Making inroads with maternal health

Learn how Indiana and Washington, D.C., are tackling critical maternal health equity disparities.

The foundational forces affecting pharma today and beyond

Learn about the 3 key trends manufacturers should consider when planning for 2025 from Advisory Board and Optum Life Sciences experts.